Learn / Stock guides / BMY vs JNJ
CompareBristol Myers Squibb co vs Johnson & Johnson: how do the stocks compare?
BMY and JNJ side by side, in plain English. This is an explanation of the two businesses, not a recommendation to buy either one.
| BMY | JNJ | |
|---|---|---|
| Ticker | BMY | JNJ |
| Exchange | NYSE | NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers General | Drug Manufacturers General |
| Size | large cap | mega cap |
| Market value | 124.9 billion dollars | 617 billion dollars |
Bristol Myers Squibb co (BMY)
Bristol Myers Squibb co trades on the New York Stock Exchange under the ticker BMY. It is a large cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 124.9 billion dollars.
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
Johnson & Johnson (JNJ)
Johnson & Johnson trades on the New York Stock Exchange under the ticker JNJ. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 617 billion dollars.
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
Follow BMY and JNJ every day
Add both to your watchlist and read a free plain English brief every trading day at 5 PM ET.
Start my free briefCommon questions
What is the difference between BMY and JNJ?
Bristol Myers Squibb co trades on the New York Stock Exchange under the ticker BMY. It is a large cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 124.9 billion dollars. Johnson & Johnson trades on the New York Stock Exchange under the ticker JNJ. It is a mega cap company in the drug manufacturers general industry, part of the healthcare sector, with a market value of about 617 billion dollars.
Which is bigger, Bristol Myers Squibb co or Johnson & Johnson?
Johnson & Johnson has the larger market value, at about 617 billion dollars.
Are Bristol Myers Squibb co and Johnson & Johnson in the same industry?
Yes. Both are in the drug manufacturers general industry.
Educational information, not financial advice. Figures are approximate and do not include live prices.